Literature DB >> 12105135

Differential regulation of elevated renal angiotensin II in chronic renal ischemia.

Hirobumi Tokuyama1, Koichi Hayashi, Hiroto Matsuda, Eiji Kubota, Masanori Honda, Ken Okubo, Ichiro Takamatsu, Satoru Tatematsu, Yuri Ozawa, Shu Wakino, Takao Saruta.   

Abstract

The present study was undertaken to clarify the role of intrarenal angiotensin (Ang) II and its generating pathways in clipped and nonclipped kidneys of 4-week unilateral renal artery stenosis in anesthetized dogs. After 4 weeks, renal plasma flow (RPF) decreased in clipped and nonclipped kidneys (baseline, 59+/-3; clipped, 16+/-1; nonclipped, 44+/-2 mL/min; P<0.01, n=22). Renal Ang I levels increased only in clipped, whereas intrarenal Ang II contents were elevated in both clipped (from 0.7+/-0.1 to 2.0+/-0.2 pg/mg tissue) and nonclipped kidneys (from 0.6+/-0.1 to 2.5+/-0.3 pg/mg tissue). Intrarenal ACE activity was increased in nonclipped kidneys but was unaltered in clipped kidneys. An angiotensin receptor antagonist (olmesartan medoxomil) given into the renal artery markedly restored RPF, and dilated both afferent and efferent arterioles (using intravital videomicroscopy). Furthermore, in clipped kidneys, the elevated Ang II was suppressed by a chymase inhibitor, chymostatin (from 2.1+/-0.6 to 0.8+/-0.1 pg/mg tissue; P<0.05), but not by cilazaprilat. In nonclipped kidneys, in contrast, cilazaprilat, but not chymostatin, potently inhibited the intrarenal Ang II generation (from 2.4+/-0.3 to 1.5+/-0.2 pg/mg tissue; P<0.05). Finally, [Pro11-D-Ala12]Ang I (an inactive precursor that yields Ang II by chymase but not by ACE; 1 to 50 nmol/kg) markedly elevated intrarenal Ang II in clipped, but not in nonclipped, kidneys. In conclusion, renal Ang II contents were elevated in both clipped and nonclipped kidneys, which contributed to the altered renal hemodynamics and microvascular tone. Furthermore, the mechanisms for intrarenal Ang II generation differ, and chymase activity is enhanced in clipped kidneys, whereas ACE-mediated Ang II generation is possibly responsible for elevated Ang II contents in nonclipped kidneys.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105135     DOI: 10.1161/01.hyp.0000022060.13995.ed

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  The importance of the intrarenal renin-angiotensin system.

Authors:  Juan Carlos Q Velez
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-09

2.  Use of renin-angiotensin inhibitors in people with renal artery stenosis.

Authors:  Kaleigh L Evans; Katherine R Tuttle; David A Folt; Taylor Dawson; Steven T Haller; Pamela S Brewster; Wencan He; Kenneth Jamerson; Lance D Dworkin; Donald E Cutlip; Timothy P Murphy; Ralph B D'Agostino; William Henrich; Christopher J Cooper
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

3.  Chymase increases glomerular albumin permeability via protease-activated receptor-2.

Authors:  Ram Sharma; Vidudala Prasad; Ellen T McCarthy; Virginia J Savin; Kottarappat N Dileepan; Daniel J Stechschulte; Elias Lianos; Thomas Wiegmann; Mukut Sharma
Journal:  Mol Cell Biochem       Date:  2006-11-11       Impact factor: 3.396

4.  Differential expression of the angiotensin-(1-12)/chymase axis in human atrial tissue.

Authors:  Sayaka Nagata; Jasmina Varagic; Neal D Kon; Hao Wang; Leanne Groban; Stephen W Simington; Sarfaraz Ahmad; Louis J Dell'Italia; Jessica L VonCannon; Dwight Deal; Carlos M Ferrario
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-06-16

Review 5.  Intrarenal angiotensin II and hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa Prieto-Carrasquero
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

6.  Nicotine augments glomerular injury in a rat model of acute nephritis.

Authors:  Edgar A Jaimes; Run-Xia Tian; Mahesh S Joshi; Leopoldo Raij
Journal:  Am J Nephrol       Date:  2008-10-10       Impact factor: 3.754

Review 7.  Nicotine signaling and progression of chronic kidney disease in smokers.

Authors:  Gaurav Jain; Edgar A Jaimes
Journal:  Biochem Pharmacol       Date:  2013-07-26       Impact factor: 5.858

8.  Impact of Mast Cell Chymase on Renal Disease Progression.

Authors:  Haimanot Wasse; Nawazish Naqvi; Ahsan Husain
Journal:  Curr Hypertens Rev       Date:  2012-02-01

Review 9.  Endovascular versus medical therapy for atherosclerotic renovascular disease.

Authors:  Mark Shipeng Yu; David A Folt; Christopher A Drummond; Steven T Haller; Emily L Cooper; Pamela Brewster; Kaleigh L Evans; Christopher J Cooper
Journal:  Curr Atheroscler Rep       Date:  2014-12       Impact factor: 5.113

10.  Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters.

Authors:  Yu-Yan Fan; Akira Nishiyama; Yoshihide Fujisawa; Hiroyuki Kobori; Daisuke Nakano; Junji Matsuura; Naoki Hase; Hirofumi Hitomi; Hideyasu Kiyomoto; Hidenori Urata; Masakazu Kohno
Journal:  J Pharmacol Sci       Date:  2009-08-29       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.